[
    [
        {
            "time": "",
            "original_text": "药明巨诺上市今日上市！医药界首富浮出！",
            "features": {
                "keywords": [
                    "药明巨诺",
                    "上市",
                    "医药界",
                    "首富"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明巨诺上市今日上市！医药界首富浮出！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "宁德时代与康龙化成：我们如何投资飞驰中的中国科技快车",
            "features": {
                "keywords": [
                    "宁德时代",
                    "康龙化成",
                    "投资",
                    "科技"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "宁德时代与康龙化成：我们如何投资飞驰中的中国科技快车",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【异动股】药明康德(02359-HK)涨4.04%",
            "features": {
                "keywords": [
                    "药明康德",
                    "涨",
                    "4.04%"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】药明康德(02359-HK)涨4.04%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "一文了解2020年中国医药制造外包(CMO)竞争格局 行业集中度低、合全药业龙头地位稳固",
            "features": {
                "keywords": [
                    "医药制造外包",
                    "CMO",
                    "竞争格局",
                    "合全药业",
                    "龙头地位"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "一文了解2020年中国医药制造外包(CMO)竞争格局 行业集中度低、合全药业龙头地位稳固",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "药明康德(603259)：中国医药外包龙头 引擎澎湃动力充足",
            "features": {
                "keywords": [
                    "药明康德",
                    "医药外包",
                    "龙头",
                    "动力充足"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259)：中国医药外包龙头 引擎澎湃动力充足",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "晨会聚焦201020重点关注阳光城、拓邦股份、工业机器人行业、京东数科、拓普集团、兆驰股份、华润微",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "阳光城",
                    "拓邦股份",
                    "工业机器人",
                    "京东数科",
                    "拓普集团",
                    "兆驰股份",
                    "华润微"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "房地产",
                    "科技",
                    "工业",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦201020重点关注阳光城、拓邦股份、工业机器人行业、京东数科、拓普集团、兆驰股份、华润微",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "《科学》子刊深度综述：新冠疫苗的安全性前景如何？",
            "features": {
                "keywords": [
                    "科学",
                    "新冠疫苗",
                    "安全性",
                    "前景"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "《科学》子刊深度综述：新冠疫苗的安全性前景如何？",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "靶向CD19的CAR-T疗法—血液瘤领域的明珠",
            "features": {
                "keywords": [
                    "靶向CD19",
                    "CAR-T疗法",
                    "血液瘤",
                    "领域",
                    "明珠"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "靶向CD19的CAR-T疗法—血液瘤领域的明珠",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]